Drugs / adipose stem cells
adipose stem cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT03916211 | Apr 2019 → Jan 2020 | ulcer of lower limbs | Maoquan Li | Unknown | No outcome recorded |
News releases announcing trial results or a regulatory action · 1
| Date | Issuer | Release |
|---|---|---|
| 2023-12-18 | Personalized Stem Cells, Inc. | Results PSC Knee Osteoarthritis Stem Cell Research Results personalizedstemcells.com ↗
Based on MRI findings, other clinical trials have shown that ASC therapy can improve the knee cartilage health up to 5 years. |
All press releases naming this drug 2 releases
| Date | Issuer | Release |
|---|---|---|
| 2024-04-23 | Personalized Stem Cells, Inc. | Choosing Wisely: A Comprehensive Comparison of Umbilical Cord and Adipose Stem Cells for Regenerative Therapies personalizedstemcells.com ↗ |
| 2023-12-18 | Personalized Stem Cells, Inc. | PSC Knee Osteoarthritis Stem Cell Research Results personalizedstemcells.com ↗ |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | adipose stem cells | “intramuscular injection of adipose stem cells treat diabetic foot” NCT03916211 ↗ |
| Known as | Mesenchymal Stem Cells | “Mesenchymal Stem Cells(MSCs)from fat sources” NCT03916211 ↗ |
| Known as | MSCs | “Mesenchymal Stem Cells(MSCs)from fat sources” NCT03916211 ↗ |
| Modality | Cell therapy | “autologous adipose stem cell therapy” NCT03916211 ↗ |
| Route | Intramuscular | “purified adipose stem cells were injected intramuscularly into lower extremities” NCT03916211 ↗ |